Show Notes
Send us Fan Mail What does the stock market have to do with curing type 1 diabetes? Actually...a lot. In this episode of the Diabetes Nerd Podcast, my friend Julia Flaherty joins me to pull back the curtain on the business side of diabetes research. We talk about how biotech companies raise money, why investors get excited about clinical trial results, what happens when a company gets acquired, and why so many people living with T1D are becoming shareholders themselves. If you've ever wondere...
More from Diabetes Nerd
Send us Fan Mail Sixty-two percent of U.S. adults with type 1 diabetes are living with overweight or obesity. That’s nearly identical to the general population, according to a 2023 Johns Hopkins study published in Annals of Internal Medicine, and it shatters the old myth that T1D is a “thin person’s disease.” https://publichealth.jhu.edu/2023/overweight-and-obesity-in-people-with-type-1-diabetes-nearly-same-as-general-population So what’s going on? Part of the answer may be how we’ve been tau...
Send us Fan Mail Most continuous glucose monitors (CGMs) need regular changes and careful upkeep. Eversense lasts a full year, which can be a relief for people dealing with skin irritation, accuracy concerns, and frequent sensor swaps. On the latest episode of the Diabetes Nerd Podcast, I talk with Brian Hansen, President of Senseonics' CGM division, and COO Mukul Jane about the Eversense 365-day implantable CGM. We discuss the implanted sensor, removable transmitter, and optical techno...
Send us Fan Mail Insulin and diabetes technology help people manage type 1 diabetes (T1D), but what would it take to go beyond management? In this episode of the Diabetes Nerd Podcast, I talk with Sernova CEO Jonathan Rigby, who has lived with T1D for more than 40 years. We discuss the company’s implantable cell pouch and its effort to create a functional cure. Rigby explains how the approach works, what challenges remain, and why he believes the future of treatment may look very different...
Send us Fan Mail I’ve spent years learning how to speak up for the diabetes care I need—and I know how frustrating it can be when a provider or insurance company says no. In this episode of the Diabetes Nerd Podcast, I talk with Lily Mees and Paola Acevedo about how people with diabetes can advocate for themselves and navigate a complicated healthcare system. We discuss preparing for appointments, asking clear questions, finding a care team that listens, and what to do when insurance denies ...
Send us Fan Mail "A cure is five years away." If you've lived with type 1 diabetes for any length of time, you've heard it. Maybe at diagnosis, maybe from a well-meaning doctor, maybe on repeat for decades. Then five years pass, and five more, and the question gets harder to ignore: where is it? That frustration is fair. So is the skepticism. But Seraxis CEO Will Rust believes we are closer to a cure for T1D than we've ever been, and he makes his case in this episode. We dig into what Sera...